Can-Fite BioPharma reports financial results, provides updates on drug development programs

November 27, 2015

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the nine months ended September 30, 2015 and updates on its drug development programs.

Previous Article
Lannett acquires Kremers Urban Pharmaceuticals from UCB for $1.23 billion
Lannett acquires Kremers Urban Pharmaceuticals from UCB for $1.23 billion

Lannett Company, Inc. today announced that it has completed the acquisition of Kremers Urban Pharmaceutical...

Next Article
Incidence of HIV in Europe reaches record high
Incidence of HIV in Europe reaches record high

Results of recent surveillance conducted by the European Centre for Disease Prevention and Control (ECDC) a...